ArticleWiener klinische Wochenschrift2020

Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis.

Robert Wakolbinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.